Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):735-8. doi: 10.1016/s0360-3016(00)00481-8.

Abstract

Purpose: To evaluate the efficacy of total abdominopelvic (TAI) and total body irradiation (TBI) in heavily pretreated follicular non-Hodgkin's lymphoma (NHL).

Patients and methods: From 1983 to 1998, 34 patients received TAI (n = 22) or TBI (n = 12). All had Stage III or IV, Class B, C, D NHL in the working formulation and failed after receiving 1-5 regimens of chemotherapy. TAI was given at 20 Gy over a 3-week period. TBI was delivered in two successive half-body irradiations of 15 Gy over a 2-week period with a 4-week interval between each.

Results: Mean follow-up from TAI or TBI was 120 months (range, 6-180). Seventy-six percent of patients achieved complete response and 24% partial response. Median survival was 62 months, 5-year and 10-year overall survival was 59% and 41%, and disease-free survival was 56% and 30%, respectively. Grade III or IV toxicity was gastrointestinal in 38% of patients and hematologic in 30%. No toxic death or delayed complications were observed.

Conclusion: Extended-field irradiation is feasible and efficient after failure of chemotherapy in follicular NHL.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / pathology
  • Lymphoma, Follicular / radiotherapy*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Salvage Therapy
  • Survival Analysis
  • Whole-Body Irradiation* / adverse effects